243 results on '"Span, Paul N"'
Search Results
2. Evaluation of Ex Vivo Adrenocorticotropic Hormone Responsiveness of Human Fetal Testis
3. Hormonal control during infancy and testicular adrenal rest tumor development in CAH males - a retrospective multi-center cohort study
4. Obesity-associated changes in molecular biology of primary breast cancer
5. The association between hormonal control during infancy and testicular adrenal rest tumor development in males with congenital adrenal hyperplasia
6. Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase
7. Supplementary Table S2 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
8. Table S1 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
9. Supplementary Table S2 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
10. Supplementary data from A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer
11. Supplementary Tables and Figures from Hypoxic Activation of the PERK/eIF2α Arm of the Unfolded Protein Response Promotes Metastasis through Induction of LAMP3
12. Figure S3 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
13. Table S3 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
14. Figure S3 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
15. Supplementary Data from Hypoxic Activation of the PERK/eIF2α Arm of the Unfolded Protein Response Promotes Metastasis through Induction of LAMP3
16. Supplementary Table S3 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
17. Supplementary Table S1 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
18. Figure S5 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
19. Supplementary Table S1 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
20. Table S2 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
21. Figure S5 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
22. Supplementary data from A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer
23. Figure S2 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
24. Figure S1 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
25. Figure S4 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
26. Figure S4 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
27. Supplementary Table S3 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
28. Supplementary Tables and Figures from Hypoxic Activation of the PERK/eIF2α Arm of the Unfolded Protein Response Promotes Metastasis through Induction of LAMP3
29. Supplementary Data from Hypoxic Activation of the PERK/eIF2α Arm of the Unfolded Protein Response Promotes Metastasis through Induction of LAMP3
30. Figure S1 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
31. Figure S2 from Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
32. Data from TRPM7 Is Required for Breast Tumor Cell Metastasis
33. Supplementary Figure 3 from TRPM7 Is Required for Breast Tumor Cell Metastasis
34. Supplementary Figure 3 from TRPM7 Is Required for Breast Tumor Cell Metastasis
35. Supplementary Figure 1 from TRPM7 Is Required for Breast Tumor Cell Metastasis
36. Supplementary Figure 4 from TRPM7 Is Required for Breast Tumor Cell Metastasis
37. Data from TRPM7 Is Required for Breast Tumor Cell Metastasis
38. Data from Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion
39. Supplementary Figure Legends 1-5 from TRPM7 Is Required for Breast Tumor Cell Metastasis
40. Supplementary Figure 4 from TRPM7 Is Required for Breast Tumor Cell Metastasis
41. Supplementary Table 2 from TRPM7 Is Required for Breast Tumor Cell Metastasis
42. Supplementary Figure 1 from Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion
43. Supplementary Table 1 from TRPM7 Is Required for Breast Tumor Cell Metastasis
44. Supplementary Figure 1 from Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion
45. Supplementary Figure 5 from TRPM7 Is Required for Breast Tumor Cell Metastasis
46. Supplementary Figure 2 from TRPM7 Is Required for Breast Tumor Cell Metastasis
47. Supplementary Figure 2 from TRPM7 Is Required for Breast Tumor Cell Metastasis
48. Supplementary Figure 1 from TRPM7 Is Required for Breast Tumor Cell Metastasis
49. Quantitative Imaging of Hypoxic CAIX-Positive Tumor Areas with Low Immune Cell Infiltration in Syngeneic Mouse Tumor Models
50. Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.